Anders Wimo

About me
Publications
Public outreach and news

About me

MD, PhD, Family physician since more than 30 years in Nordanstig, Region of Gävleborg and also in parallel researcher in dementia and elderly care. I live in Hudiksvall with my wife, two grown-up children and one grandchild.

Utbildning
MD 1980, Specialist in family medicine 1985, PhD 1990

Akademiska priser och utmärkelser
Inga Sandeborgs pris 2016

Research

My research main focuses are in epidemiologic, health economic and clinical studies on elderly in general and dementia in particular, with both Swedish and international collaborations. I am a member of the steering committee of the population-based project Swedish National study on Aging and Care (SNAC) and I was one of the research founders of the Swedish dementia registry SveDem.

I have several times worked as an expert for the Swedish national board of health and welfare and participated in its update of the Swedish guidelines for dementia care. I co-authored WHO’s report Dementia: a public health priority from 2012 and I am currently involved in WHO’s GDO project. I was one of the contributors to WHO´s report “The Global status report on the public response to dementia” in 2021. I have co-authored ADI´s World Alzheimer Reports 2010 and 2015 about global dementia epidemiology and costs, and I was the principal author of ADI’s 2018 report on global estimates of informal care time. I also contributed to World Alzheimer Reports 2021 and 2022.

I have participated and still participates in many EU-projects (e.g. ALCOVE, RightTimePlaceCare, ACTIFCARE, MOPEAD, PRODEMOS, MIND-AD, ADDITION, EURO-FINGERS, PROMINENT). I am one of the creators of the Resource Utilisation in Dementia (RUD) instrument, which is used worldwide in health economic research in dementia.

Articles

Article: VALUE IN HEALTH. 2024;26(12):S419
IPECAD MODELING WORKSHOP 2023 CROSS COMPARISON CHALLENGE ON COST-EFFECTIVENESS MODELS IN ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
Handels R; Herring W; Kamgar F; Gustavsson A; Skoldunger A; Wimo A; Tate A; Winblad B; Stellick CB; Bruck C; Green C; de Kok I; Hlavka J; Mar J; Urbich M; Soto-Gordoa M; Pemberton-Ross P; Aye S; Jonsson L
Article: VALUE IN HEALTH. 2024;:S1098-3015(24)02790-6
New International Pharmaco-Economic Collaboration on Alzheimer's Disease (IPECAD) Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases.
Handels R; Herring WL; Grimm S; Sköldunger A; Winblad B; Wimo A; Jönsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2024;39(7):e6126
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project
Wimo A; Kirsebom B-E; Timon-Reina S; Vromen E; Selnes P; Bon J; Emersic A; Kramberger MG; Speh A; Visser PJ; Winblad B; Fladby T
Article: BMC MEDICINE. 2024;22(1):236
Validation of the Health Assessment Tool (HAT) based on four aging cohorts from the Swedish National study on Aging and Care
Abbadi A; Kokoroskos E; Stamets M; Vetrano DL; Orsini N; Elmstahl S; Fagerstrom C; Wimo A; Skoldunger A; Berglund JS; Olsson CB; Wachtler C; Fratiglioni L; Calderon-Larranaga A
Article: THE LANCET. HEALTHY LONGEVITY. 2024;5(6):e431-e442
Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness-implementation trial
van Charante EPM; Hoevenaar-Blom MP; Song M; Andrieu S; Barnes L; Birck C; Brooks R; Coley N; Eggink E; Georges J; Hafdi M; van Gool WA; Handels R; Hou H; Lyu J; Niu Y; Song L; Wang W; Wang Y; Wimo A; Yu Y; Zhang J; Zhang W; Brayne C; Wang W; Richard E
Article: ALZHEIMERS RESEARCH & THERAPY. 2024;16(1):118
Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD_mini randomized controlled trial
Thunborg C; Wang R; Rosenberg A; Sindi S; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Hakansson K; Kekkonen E; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Rydstrom A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2024;99(2):471-476
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment
Zupanic E; Emersic A; Wimo A; Winblad B; Speh A; Kramberger MG
Article: ALZHEIMERS & DEMENTIA. 2024;20(2):809-818
Predicting sojourn times across dementia disease stages, institutionalization, and mortality
Tate AE; Bouteloup V; van Maurik IS; Jean D; Mank A; Speh A; Boilet V; van Harten A; Eriksdotter M; Wimo A; Dufouil C; van der Flier WM; Joensson L
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(1):155-161
Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers
Mattke S; Gustavsson A; Jacobs L; Kern S; Palmqvist S; Eriksdotter M; Skoog I; Winblad B; Wimo A; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S21)
Cost‐effectiveness of amyloid‐targeting therapies: modelling based on 5724 biomarker positive AD patients in the Swedish Registry of Cognitive Disorders
Jönsson L; Skillback T; Kern S; Winblad B; Blennow K; Eriksdotter M; Zetterberg H; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S22)
Predicting Sojourn Times across Dementia Disease Stages, Institutionalization, and Mortality
Tate A; Bouteloup V; van Maurik IS; Mank A; Speh A; Eriksdotter M; Wimo A; Dufouil C; van der Flier WM; Jönsson L
Journal article: VALUE IN HEALTH. 2023;26(12):s419
MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias
Handels R; Herring W; Kamgar F; Gustavsson A; Skoldunger A; Wimo A; Tate A; Winblad B; Stellick CB; Bruck C; Green C; de Kok I; Hlavka J; Mar J; Urbich M; Soto-Gordoa M; Pemberton-Ross P; Aye S; Jönsson L; Participants W
Article: LAKARTIDNINGEN. 2023;120:23062
Träning och protein för funktion och självtillit.
Boström A-M; Faxén-Irving G; Franzén E; Grönstedt H; Seiger Å; Vikström S; Wimo A; Cederholm T
Article: ALZHEIMERS RESEARCH & THERAPY. 2023;15(1):200
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Joensson L
Article: ALZHEIMERS & DEMENTIA. 2023;19(7):2865-2873
The worldwide costs of dementia in 2019
Wimo A; Seeher K; Cataldi R; Cyhlarova E; Dielemann JL; Frisell O; Guerchet M; Jonsson L; Malaha AK; Nichols E; Pedroza P; Prince M; Knapp M; Dua T
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;29:100657
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Joensson L; Wimo A; Handels R; Johansson G; Boada M; Engelborghs S; Froelich L; Jessen F; Kehoe PG; Kramberger M; de Mendon A; Ousset PJ; Scarmeas N; Visser PJ; Waldemar G; Winblad B
Article: ALZHEIMERS & DEMENTIA. 2023;19(5):1800-1820
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge
Handels RLH; Green C; Gustavsson A; Herring WL; Winblad B; Wimo A; Skoldunger A; Karlsson A; Anderson R; Belger M; Bruck C; Espinosa R; Hlavka JP; Jutkowitz E; Lin P-J; Mendez ML; Mar J; Shewmaker P; Spackman E; Tafazzoli A; Tysinger B; Jonsson L
Article: ALZHEIMERS & DEMENTIA. 2023;19(3):999-1008
Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program
Wimo A; Handels R; Antikainen R; Eriksdotter M; Jonsson L; Knapp M; Kulmala J; Laatikainen T; Lehtisalo J; Peltonen M; Skoldunger A; Soininen H; Solomon A; Strandberg T; Tuomilehto J; Ngandu T; Kivipelto M
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2023;77(2):125-132
Variability in perceived burden and health trajectories among older caregivers: a population-based study in Sweden
Kirvalidze M; Beridze G; Wimo A; Morin L; Calderon-Larranaga A
Journal article: US NEUROLOGY. 2023;19(1):14
Lecanemab: The Price of a Breakthrough
Wimo A; Jönsson L; Johansson G; Winblad B
Article: FRONTIERS IN NEUROLOGY. 2023;14:1175922
Precision medicine in neurodegeneration: the IHI-PROMINENT project
Tate A; Suarez-Calvet M; Ekelund M; Eriksson S; Eriksdotter MM; Van der Flier W; Georges J; Kivipelto MG; Kramberger M; Lindgren P; Lopez JDG; Lotjonen J; Persson S; Pla S; Solomon A; Thurfjell L; Wimo A; Winblad B; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2022;18(S11)
Costs of dementia in Europe: a systematic literature review and meta‐analysis
Jönsson L; Frisell O; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2022;89(2):623-632
Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline
Janssen N; Handels RL; Wimo A; Antikainen R; Laatikainen T; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Evers SMAA; Verhey FRJ; Ngandu T
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2022;50(6):748-755
Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden
Axenhus M; Schedin-Weiss S; Winblad B; Wimo A
Article: ALZHEIMERS & DEMENTIA. 2022;18(6):1119-1127
Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
Boada M; Rodrigo A; Jessen F; Wimblad B; Kramberger M; Visser PJ; Simo R; Rodriguez-Gomez O; Ciudin A; Georges J; Dumas A; Maguire P; Krivec D; Wimo A; Valero S; Alegret M; Jamilis L; Zwan M; Sannemann L; Arrufat J; Stomrud E; Johansson G; Shering C; Glaysher B; Stewart N; Belger M; Iradier F; Campo L
Article: ZDRAVSTVENO VARSTVO. 2022;61(2):76-84
Cost of diagnosing and treating cognitive complaints: One-year cost-evaluation study in a patient cohort from a Slovenian memory clinic
Zupanic E; Wimo A; Winblad B; Gregoric Kramberger M
Article: BMC GERIATRICS. 2022;22(1):365
Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
Axenhus M; Schedin-Weiss S; Tjernberg L; Wimo A; Eriksdotter M; Bucht G; Winblad B
Article: ECLINICALMEDICINE. 2022;45:101337
Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise
Pedroza P; Miller-Petrie MK; Chen C; Chakrabarti S; Chapin A; Hay S; Tsakalos G; Wimo A; Dieleman JL
Journal article: BMJ OPEN. 2022;12(2):e055984
Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands.
Eggink E; Hafdi M; Hoevenaar-Blom MP; Richard E; Moll van Charante EP; PRODEMOS-consortium
Article: LANCET PUBLIC HEALTH. 2022;7(2):e105-e125
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
GBD 2019 Dementia Forecasting Collaborators
Journal article: LANCET PUBLIC HEALTH. 2022;7(2):E105-E125
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Nichols E; Steinmetz JD; Vollset SE; Fukutaki K; Chalek J; Abd-Allah F; Abdoli A; Abualhasan A; Abu-Gharbieh E; Akram TT; Al Hamad H; Alahdab F; Alanezi FM; Alipour V; Almustanyir S; Amu H; Ansari I; Arabloo J; Ashraf T; Astell-Burt T; Ayano G; Ayuso-Mateos JL; Baig AA; Barnett A; Barrow A; Baune BT; Bejot Y; Bezabhe WMM; Bezabih YM; Bhagavathula AS; Bhaskar S; Bhattacharyya K; Bijani A; Biswas A; Bolla SR; Boloor A; Brayne C; Brenner H; Burkart K; Burns RA; Camera LA; Cao C; Carvalho F; Castro-de-Araujo LFS; Catala-Lopez F; Cerin E; Chavan PP; Cherbuin N; Chu D-T; Costa VM; Couto RAS; Dadras O; Dai X; Dandona L; Dandona R; De La Cruz-Gongora V; Dhamnetiya D; da Silva DD; Diaz D; Douiri A; Edvardsson D; Ekholuenetale M; El Sayed I; El-Jaafary SI; Eskandari K; Eskandarieh S; Esmaeilnejad S; Fares J; Faro A; Farooque U; Feigin VL; Feng X; Fereshtehnejad S-M; Fernandes E; Ferrara P; Filip I; Fillit H; Fischer F; Gaidhane S; Galluzzo L; Ghashghaee A; Ghith N; Gialluisi A; Gilani SA; Glavan I-R; Gnedovskaya EV; Golechha M; Gupta R; Gupta VB; Gupta VK; Haider MR; Hall BJ; Hamidi S; Hanif A; Hankey GJ; Haque S; Hartono RK; Hasaballah AI; Hasan MT; Hassan A; Hay SI; Hayat K; Hegazy MI; Heidari G; Heidari-Soureshjani R; Herteliu C; Househ M; Hussain R; Hwang B-F; Iacoviello L; Iavicoli I; Ilesanmi OS; Ilic IM; Ilic MD; Irvani SSN; Iso H; Iwagami M; Jabbarinejad R; Jacob L; Jain V; Jayapal SK; Jayawardena R; Jha RP; Jonas JB; Joseph N; Kalani R; Kandel A; Kandel H; Karch A; Kasa AS; Kassie GM; Keshavarz P; Khan MAB; Khatib MN; Khoja TAM; Khubchandani J; Kim MS; Kim YJ; Kisa A; Kisa S; Kivimaki M; Koroshetz WJ; Koyanagi A; Kumar GA; Kumar M; Lak HM; Leonardi M; Li B; Lim SS; Liu X; Liu Y; Logroscino G; Lorkowski S; Lucchetti G; Saute RL; Magnani FG; Malik AA; Massano J; Mehndiratta MM; Menezes RG; Meretoja A; Mohajer B; Ibrahim NM; Mohammad Y; Mohammed A; Mokdad AH; Mondello S; Moni MA; Moniruzzaman M; Mossie TB; Nagel G; Naveed M; Nayak VC; Kandel SN; Nguyen TH; Oancea B; Otstavnov N; Otstavnov SS; Owolabi MO; Panda-Jonas S; Kan FP; Pasovic M; Patel UK; Pathak M; Peres MFP; Perianayagam A; Peterson CB; Phillips MR; Pinheiro M; Piradov MA; Pond CD; Potashman MH; Pottoo FH; Prada SI; Radfar A; Raggi A; Rahim F; Rahman M; Ram P; Ranasinghe P; Rawaf DL; Rawaf S; Rezaei N; Rezapour A; Robinson SR; Romoli M; Roshandel G; Sahathevan R; Sahebkar A; Sahraian MA; Sathian B; Sattin D; Sawhney M; Saylan M; Schiavolin S; Seylani A; Sha F; Shaikh MA; Shaji KS; Shannawaz M; Shetty JK; Shigematsu M; Shin JI; Shiri R; Santos Silva DA; Silva JP; Silva R; Singh JA; Skryabin VY; Skryabina AA; Smith AE; Soshnikov S; Spurlock EE; Stein DJ; Sun J; Tabares-Seisdedos R; Thakur B; Timalsina B; Tovani-Palone MR; Bach XT; Tsegaye GW; Tahbaz SV; Valdez PR; Venketasubramanian N; Vlassov V; Giang TV; Linh GV; Wang Y-P; Wimo A; Winkler AS; Yadav L; Jabbari SHY; Yamagishi K; Yang L; Yano Y; Yonemoto N; Yu C; Yunusa I; Zadey S; Zastrozhin MS; Zastrozhina A; Zhang Z-J; Murray CJL; Vos T
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2022;9(1):30-39
Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress
Sindi S; Thunborg C; Rosenberg A; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Hakansson K; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Kekkonen E; Rydstrom A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
Article: JOURNAL OF MULTIDISCIPLINARY HEALTHCARE. 2022;15:2615-2622
Factors Associated with Health-Related Quality of Life in Older Persons Residing in Nursing Homes
Bostrom A-M; Cederholm T; Faxen-Irving G; Franzen E; Gronstedt H; Seiger A; Vikstrom S; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;83(3):1149-1159
A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project
Wimo A; Belger M; Bon J; Jessen F; Dumas A; Kramberger MG; Jamilis L; Johansson G; Rodrigo Salas A; Gomez OR; Sannemann L; Stoekenbroek M; Gurruchaga Telleria M; Valero S; Vermunt L; Waterink L; Winblad B; Jelle Visser P; Zwan M; Boada M
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2021;22(9):1939-1945.e3
Response and Adherence of Nursing Home Residents to a Nutrition/ Exercise Intervention
Karlsson ES; Gronstedt HK; Faxen-Irving G; Franzen E; Luiking YC; Seiger A; Vikstrom S; Wimo A; Cederholm TE; Bostrom A-M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;82(4):1461-1466
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk
Solomon A; Handels R; Wimo A; Antikainen R; Laatikainen T; Levalahti E; Peltonen M; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Ngandu T
Article: BMJ OPEN. 2021;11(6):e049762
Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial
Eggink E; Hafdi M; Hoevenaar-Blom MP; Song M; Andrieu S; Barnes LE; Birck C; Brooks RL; Coley N; Ford E; Georges J; van der Groep A; van Gool WA; Handels R; Hou H; Li D; Liu H; Lyu J; van Marwijk H; van der Meijden M; Niu Y; Sadhwani S; Wang W; Wang Y; Wimo A; Ye X; Yu Y; Zeng Q; Zhang W; Wang W; Brayne C; van Charante EPM; Richard E
Article: NEUROLOGY. 2021;96(17):E2220-E2230
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Xu H; Garcia-Ptacek S; Jonsson L; Wimo A; Nordstrom P; Eriksdotter M
Article: QUALITY OF LIFE RESEARCH. 2021;30(2):577-588
A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries
Voormolen DC; van Exel J; Brouwer W; Skoldunger A; Goncalves-Pereira M; Irving K; Bieber A; Selbaek G; Woods B; Zanetti O; Verhey F; Wimo A; Handels RLH
Article: FRONTIERS IN NEUROLOGY. 2021;12:733878
Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project
Hafdi M; Eggink E; Hoevenaar-Blom MP; Witvliet MP; Andrieu S; Barnes L; Brayne C; Brooks R; Coley N; Georges J; van der Groep A; van Marwijk H; van der Meijden M; Song L; Song M; Wang Y; Wang W; Wang W; Wimo A; Ye X; Moll van Charante EP; Richard E
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2021;13(1):e12130
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey
Sannemann L; Mueller T; Waterink L; Zwan M; Wimo A; Stomrud E; Pino S; Arrufat J; Rodriguez-Gomez O; Benaque A; Bon J; Ferreira D; Johansson G; Dron A; Dumas A; Georges J; Kramberger MG; Visser PJ; Winblad B; Campo L; Boada M; Jessen F
Journal article: ALZHEIMER'S AND DEMENTIA: TRANSLATIONAL RESEARCH AND CLINICAL INTERVENTIONS. 2021;7(1):e12200
Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
Nichols E; Abd-Allah F; Abdoli A; Abosetugn AE; Abrha WA; Abualhasan A; Abu-Gharbieh E; Akinyemi RO; Alahdab F; Alanezi FM-H; Alipour V; Ansari I; Arabloo J; Ashraf-Ganjouei A; Avan A; Ayano G; Babar Z-U; Baig AA; Banach M; Barboza MA; Barker-Collo SL; Baune BT; Bhagavathula AS; Bhattacharyya K; Bijani A; Biondi A; Birhan TA; Biswas A; Bolla SR; Boloor A; Brayne C; Brenner H; Burkart K; Burns RA; Nagaraja SB; Carvalho F; Castro-de-Araujo LFS; Catala-Lopez F; Cerin E; Cernigliaro A; Cherbuin N-L; Choi J-YJ; Chu D-T; Dagnew B; Dai X; Dandona L; Dandona R; Diaz D; Forooshani ZSD; Douiri A; Duncan BB; Edvardsson D; El-Jaafary SI; Eskandari K; Eskandarieh S; Feigin VL; Fereshtehnejad S-M; Fernandes E; Ferrara P; Filip I; Fischer F; Gaidhane S; Gebregzabiher KZ; Ghashghaee A; Gholamian A; Gnedovskaya EV; Golechha M; Gupta R; Hachinski V; Hamidi S; Hankey GJ; Maria Haro J; Hassan A; Hay SI; Heidari G; Heidari-Soureshjani R; Househ M; Hussain R; Hwang B-F; Ilic IM; Ilic MD; Irvani SSN; Iso H; Iwagami M; Jha RP; Kalani R; Kandel H; Karch A; Kasa AS; Kengne AP; Kim Y-E; Kim YJ; Kisa S; Kisa A; Kivimaki M; Komaki H; Koyanagi A; Kukull WA; Kumar GA; Kumar M; Landires I; Leonardi M; Lim SS; Liu X; Logroscino G; Lopez AD; Lorkowski S; Loy CT; Amin HIM; Manafi N; Manjunatha N; Mehndiratta MM; Menezes RG; Meretoja A; Merkin A; Metekiya WM; Misganaw AT; Mohajer B; Ibrahim NM; Mohammad Y; Mohapatra A; Mohebi F; Mokdad AH; Mondello S; Mossie TB; Mulugeta A; Nagel G; Naveed M; Nayak VC; Kandel SN; Son HN; Huong LTN; Nunez-Samudio V; Ogbo FA; Olagunju AT; Orru H; Ostojic SM; Ostroff SM; Otstavnov N; Otstavnov SS; Owolabi MO; Pathak M; Toroudi HP; Peterson CB; Hai QP; Phillips MR; Piradov MA; Pottoo FH; Prada SI; Pribadi DRA; Radfar A; Raggi A; Rahim F; Ram P; Rana J; Rashedi V; Rawaf S; Rawaf DL; Reinig N; Rezaei N; Robinson SR; Romoli M; Sachdev PS; Sahathevan R; Sahebkar A; Sahraian MA; Sattin D; Saylan M; Sayyah M; Schiavolin S; Schmidt MI; Shahid I; Shaikh MA; Shigematsu M; Shin JI; Shiri R; Siddiqi TJ; Silva JP; Singh JA; Soheili A; Spurlock EE; Szoeke CEI; Tabares-Seisdedos R; Taddele BW; Thakur B; ThekkePurakkal AS; Tovani-Palone MR; Tran BX; Travillian RS; Tripathi M; Tsegaye GW; Usman MS; Vacante M; Zuleika Velazquez D; Venketasubramanian N; Vidale S; Vlassov V; Wang Y-P; Wei J; Weiss J; Weldemariam AH; Wimo A; Wu C; Yadollahpour A; Yamagishi K; Yeshitila YG; Yonemoto N; Zadey S; Zhang Z-J; Murray CJL; Vos T
Article: THE JOURNAL OF FRAILTY & AGING. 2021;10(1):17-21
DO MALNUTRITION, SARCOPENIA AND FRAILTY OVERLAP IN NURSING-HOME RESIDENTS?
Faxen-Irving G; Luiking Y; Gronstedt H; Franzen E; Seiger A; Vikstrom S; Wimo A; Bostrom A-M; Cederholm T
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD
Winblad B; Jessen F; Kramberger MG; Visser PJ; Rodrigo A; Jamilis L; Rodriguez‐Gomez O; Sannemann L; Zwan MD; Bon J; Johansson G; Nelvig A; Haglund A; Jelic V; Campo L; Wimo A; Boada M; Consortium M
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
Long‐term treatment with cholinesterase inhibitors in Alzheimer's disease is associated with modest but persisting benefits on cognition and reduced mortality
Eriksdotter M; Xu H; Jönsson L; Wimo A; Nordström P; Garcia‐Ptacek S
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)
Prevention of dementia using mobile phone applications (PRODEMOS): A randomized controlled trial in progress
Eggink E; van Charante EPM; Hoevenaar‐Blom MP; Andrieu S; Hafdi M; Coley N; Sadhwani S; Wimo A; Barnes L; Handels R; Kivipelto M; Song M; Georges J; van Der Groep B; van der Meijden M; Wang Y; Wang W; van Gool WA; van Marwijk H; Brayne C; Richard E
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
General practitioners’ opinion on early and pre‐dementia diagnosis of AD: A MOPEAD project survey in five European countries
Sannemann L; Müller T; Waterink L; Zwan MD; Wimo A; Stomrud E; Pino S; Espinosa JA; Rodriguez‐Gomez O; Benaque A; Bon J; Dron A; Ferreira D; Johansson G; Dumas A; Georges J; Kramberger MG; Visser PJ; Winblad B; Campo L; Boada M; Jessen F; Consortium TM
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
Pre‐screening models for patient engagement: The MOPEAD project
Boada M; Winblad B; Jessen F; Visser PJ; Kramberger MG; Rodrigo A; Simó R; Rodriguez O; Sannemann L; Bon J; Zwan MD; Alegret M; Sanabria A; Rosende‐Roca M; Krivec D; Jamilis L; Trigueros P; Kivipelto M; Johansson G; Wimo A; Valero S; Shering C; Glaysher B; Tarraga L; Dumas A; Georges J; Campo L
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S7)
Informal care time in dementia by cognitive, functional and behavioral disease severity from eight longitudinal cohorts across multiple countries
Handels R; Jönsson L; Green C; Winblad B; Wimo A; Actifcare ID
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S8)
A cost‐consequence analysis of early detection of AD in the MOPEAD project — A project within the EU research agenda IMI‐2
Wimo A; Belger M; Bon J; Vugt M; Jessen F; Kramberger MG; Jamilis L; Johansson G; Rodrigo A; Rodriguez‐Gomez O; Sannemann L; Stoekenbroek M; Stomrud E; Gurrutxaga M; Valero S; Vermunt L; Waterink L; Winblad B; Zwan MD; Boada M; MOPEAD
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)
Time to invest in nonpharmacological interventions for behaviours and psychological symptoms associated with dementia
Burley CV; Livingston G; Knapp MRJ; Wimo A; Norman R; Brodaty H
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(11):1609-1616.e1
Profiles of Met and Unmet Needs in People with Dementia According to Caregivers' Perspective: Results from a European Multicenter Study
Janssen N; Handels RL; Kohler S; Goncalves-Pereira M; Marques MJ; Irving K; Hopper L; Bieber A; Orrell M; Selbaek G; Michelet M; Wimo A; Zanetti O; Portolani DM; Woods B; Jelley H; Evers SMAA; Verhey FRJ
Article: THE LANCET. HEALTHY LONGEVITY. 2020;1(1):e2-e3
The art of simulation
Wimo A; Handels R; Jonsson L
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(9):1229-1237
Effect of Sit-to-Stand Exercises Combined With Protein-Rich Oral Supplementation in Older Persons: The Older Person's Exercise and Nutrition Study
Gronstedt H; Vikstrom S; Cederholm T; Franzen E; Luiking YC; Seiger A; Wimo A; Faxen-Irving G; Bostrom A-M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020;311:46-51
Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults
Magnusson P; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;75(3):891-902
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions
Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK
Article: ALZHEIMERS & DEMENTIA. 2020;16(5):789-796
Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry
Handels R; Jonsson L; Garcia-Ptacek S; Eriksdotter M; Wimo A
Article: JOURNAL OF ADVANCED NURSING. 2020;76(3):856-866
Well-being and thriving in sheltered housing versus ageing in place: Results from the U-age sheltered housing study.
Corneliusson L; Sköldunger A; Sjögren K; Lövheim H; Lindkvist M; Wimo A; Winblad B; Sandman P-O; Edvardsson D
Article: INTERNATIONAL PSYCHOGERIATRICS. 2020;32(2):267-277
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS
Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
Article: AGING & MENTAL HEALTH. 2020;24(2):272-279
Do caregiver profiles predict the use of dementia care services? Findings from the Actifcare study
Kerpershoek L; Woods B; Wolfs C; Verhey F; Jelley H; Bieber A; Stephan A; Michelet M; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques MJ; Goncalves-Pereira M; Portolani E; Zanetti O; de Vugt M; Meyer G; Broda A; Bartoszek G; Orrell M; Skoldunger A; Sjolund B-M; Engedal K; Rosvik J; Eriksen S; Joyce R; Balsinha MC; Machado A
Article: AGING & MENTAL HEALTH. 2020;24(1):162-170
A comparison of self and proxy quality of life ratings for people with dementia and their carers: a European prospective cohort study
O'Shea E; Hopper L; Marques M; Goncalves-Pereira M; Woods B; Jelley H; Verhey F; Kerpershoek L; Wolfs C; de Vugt M; Stephan A; Bieber A; Meyer G; Wimo A; Michelet M; Selbaek G; Portolani E; Zanetti O; Irving K
Article: QUALITY OF LIFE RESEARCH. 2020;29(1):237-251
A validation study of the ICECAP-O in informal carers of people with dementia from eight European Countries
Perry-Duxbury M; van Exel J; Brouwer W; Skoldunger A; Goncalves-Pereira M; Irving K; Meyer G; Selbaek G; Woods B; Zanetti O; Verhey F; Wimo A; Handels RLH
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2020;35(1):45-52
Is there equity in initial access to formal dementia care in Europe? The Andersen Model applied to the Actifcare cohort
Kerpershoek L; de Vugt M; Wolfs C; Orrell M; Woods B; Jelley H; Meyer G; Bieber A; Stephan A; Selbaek G; Michelet M; Wimo A; Handels R; Irving K; Hopper L; Goncalves-Pereira M; Balsinha C; Zanetti O; Portolani D; Verhey F
Article: ALZHEIMERS & DEMENTIA. 2019;15(10):1309-1321
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Skoldunger A; Jonsson L
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(8):988-994.e2
Using an Integrated Clinical and Functional Assessment Tool to Describe the Use of Social and Medical Care in an Urban Community-Dwelling Swedish Older Population
Santoni G; Meinow B; Wimo A; Marengoni A; Fratiglioni L; Calderon-Larranaga A
Article: BMJ OPEN. 2019;9(7):e026733
Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey
Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_4):p245
P1‐033: ASSOCIATION WITH REDUCED MORTALITY USING CHOLINESTERASE INHIBITORS IN PATIENTS WITH DEMENTIA: DATA FROM SVEDEM, THE SWEDISH DEMENTIA REGISTRY
Xu H; Garcia-Ptacek S; Jonsson L; Wimo A; Nordström P; Eriksdotter M
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_31):p1636
O5‐08‐04: A NEW OPEN‐SOURCE MODELING FRAMEWORK TO ASSESS COST EFFECTIVENESS OF EARLY INTERVENTION IN ALZHEIMER'S DISEASE
Green C; Handels R; Gustavsson A; Wimo A; Skoldunger A; Winblad B; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_31):p1637
O5‐08‐05: STRUCTURAL UNCERTAINTY AND CROSS‐VALIDATION OF DECISION MODELS IN THE AD SETTING: ANSWERING QUESTIONS FROM POLICY MAKERS ON THE RELIABILITY OF HEALTH‐ECONOMIC MODELS
Handels R; Jönsson L; Green C; Eriksdotter M; Qiu C; Winblad B; Wimo A
Article: HEALTH & SOCIAL CARE IN THE COMMUNITY. 2019;27(4):e313-e322
Residing in sheltered housing versus ageing in place - Population characteristics, health status and social participation
Corneliusson L; Skoldunger A; Sjogren K; Lovheim H; Wimo A; Winblad B; Sandman P-O; Edvardsson D
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_9):p501
P1‐588: QUANTIFYING AND DESCRIBING THE NATURAL HISTORY OF AD AND ECONOMIC EFFECTS OF HYPOTHETICAL INTERVENTIONS
Wimo A; Black CM; Chekani F; Eriksdotter M; Johansson G; Handels R; Salomonsson S; Winblad B; Khandker RK
Article: ACTA MEDICA PORTUGUESA. 2019;32(5):355-367
Needs for Care and Service Use in Dementia: Baseline Assessment of Portuguese Participants in the Actifcare Cohort Study
Goncalves-Pereira M; Marques MJ; Balsinha C; Fernandes A; Machado AS; Verdelho A; Barahona-Correa B; Barrios H; Guimaraes J; Grave J; Alves L; de Almeida MC; Reis T; Orrell M; Woods B; De Vugt M; Verhey F; Wolfs C; Handels R; Kerpershoek L; Meyer G; Stephan A; Bieber A; Broda A; Bartoszek G; Jelley H; Wimo A; Skoldunger A; Sjolund B-M; Engedal K; Selbaek G; Michalet M; Rosvik J; Eriksen S; Irving K; Hopper L; Joyce R; Zanetti O; Portolani E
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2019;20(3):343-355
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia
Belger M; Haro JM; Reed C; Happich M; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(2):337-351
The use of direct care in nursing home residents: A longitudinal cohort study over 3 years
Vossius C; Selbaek G; Benth JS; Wimo A; Bergh S
Article: AGING & MENTAL HEALTH. 2019;23(1):53-59
Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia
Handels R; Wimo A
Article: PLOS ONE. 2019;14(8):e0219568
Cost analysis of day care centres in Norway
Vossius C; Selbaek G; Benth JS; Wimo A; Engedal K; Kirkevold O; Rokstad AMM
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(1):130-136
Resource use and its association to cognitive impairment, ADL functions, and behavior in residents of Swedish nursing homes: Results from the U-Age program (SWENIS study)
Skoldunger A; Wimo A; Sjogren K; Bjork S; Backman A; Sandman P-O; Edvardsson D
Article: GERONTOLOGY AND GERIATRIC MEDICINE. 2019;5:2333721419859687
Prevalence and Incidence of Atrial Fibrillation and Other Arrhythmias in the General Older Population: Findings From the Swedish National Study on Aging and Care
Lindberg T; Wimo A; Elmstahl S; Qiu C; Bohman DM; Berglund JS
Article: JOURNAL OF ADVANCED NURSING. 2018;74(12):2820-2830
Exploring resident thriving in relation to the nursing home environment: A cross-sectional study
Bjork S; Lindkvist M; Lovheim H; Bergland A; Wimo A; Edvardsson D
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(3):1165-1174
Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia
Janssen N; Handels RL; Skoldunger A; Woods B; Jelley H; Edwards RT; Orrell M; Selbaek G; Rosvik J; Goncalves-Pereira M; Marques MJ; Zanetti O; Portolani E; Irving K; Hopper L; Meyer G; Bieber A; Stephan A; Kerpershoek L; Wolfs CAG; de Vugt ME; Verhey FRJ; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(3):1027-1040
Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study
Handels RLH; Skoldunger A; Bieber A; Edwards RT; Goncalves-Pereire M; Hopper L; Irving K; Jelley H; Kerpershoek L; Marques MJ; Meyer G; Michelet M; Portolani E; Rosvik J; Selbaek G; Stephan A; de Vugt M; Wolfs C; Woods B; Zanetti O; Verhey F; Wimo A
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):421
COGNITIVE IMPAIRMENT AND ITS ASSOCIATION TO RESOURSE USE AND COSTS IN RESIDENTS IN SWEDISH NURSING HOMES
Sköldunger A; Wimo A; Sjögren K; Björk S; Backman A; Sandman PO
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):308
PREDICTORS OF PHYSICAL AND LEISURE ACTIVITIES IN RESIDENTIAL AGED CARE FACILITIES IN SWEDEN: U-AGE SWENIS STUDY
Rahman M; Sköldunger A; Sjögren K; Lövheim H; Wimo A; Winblad B; Sandman P; Edvardsson D
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):507
PREVALENCE OF SUBJECTIVE COGNITIVE DECLINE (SCD) AND THE ASSOCIATION OF MOVING TO SHELTERED HOUSING
Sköldunger A; Wimo A; Sjögren K; Sandman P; Balash L; Winblad B; Edvardsson D
Article: JOURNAL OF PARKINSONS DISEASE. 2018;8(4):553-561
No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry
Fereshtehnejad S-M; Lokk J; Wimo A; Eriksdotter M
Journal article: CLINICAL NUTRITION. 2018;37:s59-s60
Relationships between nutritional status, sarcopenia and frailty in nursing-home residents
Faxen-Irving G; Cederholm T; Grönstedt H; Franzen E; Seiger Å; Wikström S; Wimo A; Boström A-M
Article: AGING & MENTAL HEALTH. 2018;22(7):897-902
Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice
Kerpershoek L; de Vugt M; Wolfs C; Woods B; Jelley H; Orrell M; Stephan A; Bieber A; Meyer G; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_22):p1197-p1198
P3‐304: MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER'S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES
Rodriguez-Gomez O; Campo L; Datto C; Hundemer HP; Winblad B; Johansson G; Wimo A; Jessen F; Sannemann L; Visser PJ; Zwan MD; Kramberger MG; Simó R; Pérez-Garro I; Rodrigo A; Dumas A; Georges J; Krivec D; Maguire P; Semancik K; Glaysher B; Boada M
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_31):p1663
O5‐07‐04: DEMENTIA INFORMAL CARE COSTS IN THE SLOVENIAN CENTRE FOR COGNITIVE IMPAIRMENTS
Zupanic E; Wimo A; Winblad B; Petek D; Petek B; Kramberger MG
Article: ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. 2018;51(5):530-536
Access to community care for people with dementia and their informal carers Case vignettes for a European comparison of structures and common pathways to formal care
Bieber A; Stephan A; Verbeek H; Verhey F; Kerpershoek L; Wolfs C; de Vugt M; Woods RT; Rosvik J; Selbaek G; Sjolund BM; Wimo A; Hopper L; Irving K; Marques MJ; Goncalves-Pereira M; Portolani E; Zanetti O; Meyer G
Article: ALZHEIMERS & DEMENTIA. 2018;14(7):895-901
Apolipoprotein E genotypes and longevity across dementia disorders
Skillback T; Lautner R; Mattsson N; Schott JM; Skoog I; Nagga K; Kilander L; Wimo A; Winblad B; Eriksdotter M; Blennow K; Zetterberg H
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;64(s1):S41-S46
The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View
Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(9):1243-1252
The personal cost of dementia care in Japan: A comparative analysis of residence types
Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
Article: BMC GERIATRICS. 2018;18(1):138
A study protocol of Older Person's Exercise and Nutrition Study (OPEN) - a sit-to-stand activity combined with oral protein supplement - effects on physical function and independence: a cluster randomized clinical trial
Gronstedt H; Vikstrom S; Cederholm T; Franzen E; Seiger A; Wimo A; Faxen-Irving G; Bostrom A-M
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(1):e49-e57
Thriving in relation to cognitive impairment and neuropsychiatric symptoms in Swedish nursing home residents
Bjork S; Lovheim H; Lindkvist M; Wimo A; Edvardsson D
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2018;19(1):95.e1-95.e10
Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study
Costa N; Wuebker A; De Mauleon A; Zwakhalen SMG; Challis D; Leino-Kilpi H; Hallberg IR; Stephan A; Zabalegui A; Saks K; Molinier L; Wimo A; Vellas B; Sauerland D; Binot I; Soto ME
Article: GERONTOLOGY AND GERIATRIC MEDICINE. 2018;4:2333721418786565
Relationships Between Frequency of Moderate Physical Activity and Longevity: An 11-Year Follow-up Study
Rennemark M; Jogreus A; Elmstahl S; Weimer A-K; Wimo A; Sanmartin-Berglund J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(4):1477-1487
Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia
Handels RLH; Wimo A; Dodel R; Kramberger MG; Visser PJ; Luis Molinuevo J; Verhey FRJ; Winblad B
Article: NEUROBIOLOGY OF AGING. 2017;59:1-9
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients
Skillback T; Delsing L; Synnergren J; Mattsson N; Janelidze S; Nagga K; Kilander L; Hicks R; Wimo A; Winblad B; Hansson O; Blennow K; Eriksdotter M; Zetterberg H
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2017;18(8):979-986
Costs of dementia in the Czech Republic
Holmerova I; Hort J; Rusina R; Wimo A; Steffl M
Article: JOURNAL OF ADVANCED NURSING. 2017;73(8):1884-1895
Residents' engagement in everyday activities and its association with thriving in nursing homes
Bjork S; Lindkvist M; Wimo A; Juthberg C; Bergland A; Edvardsson D
Journal article: INNOVATION IN AGING. 2017;1(suppl_1):593
THE CONTENT AND FOCUS OF THE SWEDISH NATIONAL INVENTORY OF HEALTH AND CARE (SWENIS)
Backman A; Bjork S; Lövheim H; Sjögren K; Skoldunger A; Wimo A; Sandman P; Edvardsson D
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_17):p860
[P2–560]: CHALLENGES AND RECOMMENDATIONS FOR THE HEALTH‐ECONOMIC EVALUATION OF PRIMARY PREVENTION PROGRAMS FOR DEMENTIA
Handels R; Wimo A
Journal article: INNOVATION IN AGING. 2017;1(suppl_1):255
A PERSON-CENTERED APPROACH TO PREDICTING THE USE OF MEDICAL CARE AND SOCIAL SERVICES IN OLDER ADULTS
Santoni G; Calderón-Larrañaga A; Marengoni A; Wimo A; Fratiglioni L
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;57(3):797-812
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study
Reed C; Happich M; Maria Argimon J; Maria Haro J; Wimo A; Bruno G; Dodel R; Jones RW; Vellas B; Belger M
Article: ALZHEIMERS & DEMENTIA. 2017;13(3):312-321
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease
Gustavsson A; Green C; Jones RW; Foerstl H; Simsek D; de Vulpillieres FDR; Luthman S; Adlard N; Bhattacharyya S; Wimo A
Article: BMC GERIATRICS. 2017;17(1):61
Systematic pain assessment in nursing homes: a cluster-randomized trial using mixed-methods approach
Mamhidir A-G; Sjoelund B-M; Flaeckman B; Wimo A; Skoeldunger A; Engstroem M
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2017;15(1):16
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?
Reed C; Barrett A; Lebrec J; Dodel R; Jones RW; Vellas B; Wimo A; Maria Argimon J; Bruno G; Maria Haro J
Article: AGING & MENTAL HEALTH. 2017;21(1):49-57
Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health
Janssen EPCJ; de Vugt M; Kohler S; Wolfs C; Kerpershoek L; Handels RLH; Orrell M; Woods B; Jelley H; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Wimo A; Irving K; Hopper L; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey FR
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA. 2017;7(1):87-100
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.
Jones RW; Lebrec J; Kahle-Wrobleski K; Dell'Agnello G; Bruno G; Vellas B; Argimon JM; Dodel R; Haro JM; Wimo A; Reed C
Article: ALZHEIMERS & DEMENTIA. 2017;13(1):1-7
The worldwide costs of dementia 2015 and comparisons with 2010
Wimo A; Guerchet M; Ali G-C; Wu Y-T; Prina AM; Winblad B; Jonsson L; Liu Z; Prince M
Article: BULLETIN OF THE WORLD HEALTH ORGANIZATION. 2017;95(1):18-26
The economic burden of dementia in China, 1990-2030: implications for health policy
Xu J; Wang J; Wimo A; Fratiglioni L; Qiu C
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2017;21(1):17-24
FORMAL AND INFORMAL CARE OF COMMUNITY-LIVING OLDER PEOPLE: A POPULATION-BASED STUDY FROM THE SWEDISH NATIONAL STUDY ON AGING AND CARE
Wimo A; Elmstahl S; Fratiglioni L; Sjlolund B-M; Skoldunger A; Fagerstrom C; Berglund J; Lagergren M
Article: JOURNAL OF AGING AND HEALTH. 2016;28(8):1448-1464
Cost of Dementia and Its Correlation With Dependence
Akerborg O; Lang A; Wimo A; Skoldunger A; Fratiglioni L; Gaudig M; Rosenlund M
Article: ALZHEIMERS RESEARCH & THERAPY. 2016;8(1):59
The societal costs of dementia in Sweden 2012-relevance and methodological challenges in valuing informal care
Wimo A; Jonsson L; Fratiglioni L; Sandman PO; Gustavsson A; Skoldunger A; Johansson L
Journal article: NORDIC JOURNAL OF NURSING RESEARCH. 2016;36(3):168-174
The Umeå ageing and health research programme (U-Age): Exploring person-centred care and health-promoting living conditions for an ageing population
Edvardsson D; Backman A; Bergland Å; Björk S; Bölenius K; Kirkevold M; Lindkvist M; Lood Q; Lämås K; Lövheim H; Sandman P-O; Sjögren K; Sköldunger A; Wimo A; Winblad B
Article: BMC HEALTH SERVICES RESEARCH. 2016;16(1):423
Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study
Kerpershoek L; de Vugt M; Wolfs C; Jelley H; Orrel M; Woods B; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Article: BMC GERIATRICS. 2016;16(1):154
Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study
Bjork S; Juthberg C; Lindkvist M; Wimo A; Sandman P-O; Winblad B; Edvardsson D
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2016;16:83
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
Article: BMC PSYCHIATRY. 2016;16:137
The economic burden of mental disorders in China, 2005-2013: implications for health policy
Xu J; Wang J; Wimo A; Qiu C
Article: LANCET NEUROLOGY. 2016;15(5):455-532
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad B; Amouyel P; Andrieu S; Ballard C; Brayne C; Brodaty H; Cedazo-Minguez A; Dubois B; Edvardsson D; Feldman H; Fratiglioni L; Frisoni GB; Gauthier S; Georges J; Graff C; Iqbal K; Jessen F; Johansson G; Jonsson L; Kivipelto M; Knapp M; Mangialasche F; Melis R; Nordberg A; Rikkert MO; Qiu C; Sakmar TP; Scheltens P; Schneider LS; Sperling R; Tjernberg LO; Waldemar G; Wimo A; Zetterberg H
Article: BMC NEUROLOGY. 2016;16:28
The impact of dementia on drug costs in older people: results from the SNAC study
Skoldunger A; Fastbom J; Wimo A; Fratiglioni L; Johnell K
Article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2016;28(1):147-158
Horizontal and vertical targeting: a population-based comparison of public eldercare services in urban and rural areas of Sweden
Lagergren M; Fagerstrom C; Sjolund B-M; Berglund J; Fratiglioni L; Nordell E; von Strauss E; Wimo A; Elmstahl S
Article: INTERNATIONAL PSYCHOGERIATRICS. 2016;28(2):247-259
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease
Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
Article: JOURNAL OF ALZHEIMERS DISEASE. 2016;50(2):387-396
Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden
Wimo A; Sjolund B-M; Skoldunger A; Qiu C; Klarin I; Nordberg G; von Strauss E
Article: ALZHEIMERS & DEMENTIA. 2015;11(12):1470-1479
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem
Rosen C; Farahmand B; Skillback T; Nagga K; Mattsson N; Kilander L; Religa D; Wimo A; Blennow K; Winblad B; Zetterberg H; Eriksdotter M
Article: BRAIN. 2015;138(Pt 9):2716-2731
Cerebrospinal fluid tau and amyloid-β_1-42 in patients with dementia
Skillback T; Farahmand BY; Rosen C; Mattsson N; Nagga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Article: DRUGS & AGING. 2015;32(8):671-678
Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study
Skoldunger A; Fastbom J; Wimo A; Fratiglioni L; Johnell K
Article: ALZHEIMERS & DEMENTIA. 2015;11(8):896-905
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
Handels RLH; Joore MA; Tran-Duy A; Wimo A; Wolfs CAG; Verhey FRJ; Severens JL
Article: ALZHEIMERS & DEMENTIA. 2015;11(8):933-945
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
Dodel R; Belger M; Reed C; Wimo A; Jones RW; Happich M; Argimon JM; Bruno G; Vellas B; Maria Haro J
Journal article: ALZHEIMERS & DEMENTIA. 2015;11(7S_Part_3):p119
F1‐04‐01: Care interventions practices through research on policy
Wimo A
Article: ALZHEIMERS & DEMENTIA. 2015;11(4):455-461
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease
Bradley P; Akehurst R; Ballard C; Banerjee S; Blennow K; Bremner J; Broich K; Cummings J; Dening K; Dubois B; Klipper W; Leibman C; Mantua V; Luis Molinuevo J; Morgan S; Muscolo LAA; Nicolas F; Pani L; Robinson L; Siviero P; van Dam J; Van Emelen J; Wimo A; Wortmann M; Goh L
Journal article: CLINICAL NURSING STUDIES. 2015;3(2)
Comparing estimated cost per patient for dementia care: Two municipalities and Swedish national population data
Jedenius E; Wimo A; Strömqvist J; Fastbom J; Winblad B; Winblad U; Andreasen N
Journal article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2015;2(3):199-211
The Road Ahead To Cure And Prevent Alzheimer's Disease: Implementing Prevention into Primary Care.
Fougère B; Vellas B; Delrieu J; Sinclair AJ; Wimo A; Herman CJ; Fillit H; Gauthier S; Oustric S
Article: PLOS ONE. 2015;10(9):e0138901
Incidence of ADL Disability in Older Persons, Physical Activities as a Protective Factor and the Need for Informal and Formal Care - Results from the SNAC-N Project
Sjolund B-M; Wimo A; Engstrom M; von Strauss E
Article: PLOS ONE. 2015;10(2):e0116538
SveDem, the Swedish Dementia Registry - A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice
Religa D; Fereshtehnejad S-M; Cermakova P; Edlund A-K; Garcia-Ptacek S; Granqvist N; Hallback A; Kawe K; Farahmand B; Kilander L; Mattsson U-B; Nagga K; Nordstrom P; Wijk H; Wimo A; Winblad B; Eriksdotter M
Article: NEUROLOGY. 2014;83(21):1945-1953
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillback T; Farahmand B; Bartlett JW; Rosen C; Mattsson N; Nagga K; Kilander L; Religa D; Wimo A; Winblad B; Rosengren L; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_17):p608
P2‐351: TIME TRENDS IN PHYSICAL AND MENTAL FUNCTIONING COMPARING TWO POPULATIONS AGED 75+ YEARS
Sjölund B; Wimo A; Qui C; Sköldunger A; Engström M; von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_23):p783
P3‐419: COHORT EFFECTS IN THE PREVALENCE OF DEMENTIA AND SURVIVAL PATTERNS IN NORDANSTIG, A RURAL COHORT PROJECT (SNAC‐N) IN NORTHERN SWEDEN
Wimo A; Sköldunger A; Sjölund B
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2014;18(7):677-684
ANALYSIS OF BURDEN IN CAREGIVERS OF PEOPLE WITH ALZHEIMER'S DISEASE USING SELF-REPORT AND SUPERVISION HOURS
Haro JM; Kahle-Wrobleski K; Bruno G; Belger M; Dell'Agnello G; Dodel R; Jones RW; Reed CC; Vellas B; Wimo A; Argimon JM
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_15):p596
P2‐319: DRUG COSTS IN DEMENTIA CONFOUNDED BY COMORBIDITIES AND RESIDENTIAL SETTING: RESULTS FROM THE SNAC STUDY
Sköldunger A; Fastbom J; Wimo A; Sjölund B; Fratiglioni L; Johnell K
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA. 2014;4(1):51-64
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study.
Reed C; Belger M; Dell'agnello G; Wimo A; Argimon JM; Bruno G; Dodel R; Haro JM; Jones RW; Vellas B
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2014;58(3):370-375
Time trends in prevalence of activities of daily living (ADL) disability and survival: Comparing two populations (aged 78+years) living in a rural area in Sweden
Sjolund B-M; Wimo A; Qiu C; Engstrom M; von Strauss E
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2014;22(4):381-388
The Use and Costs of Formal Care in Newly Diagnosed Dementia: A Three-Year Prospective Follow-Up Study
Vossius C; Rongve A; Testad I; Wimo A; Aarsland D
Article: AGEING & SOCIETY. 2014;34(4):700-719
Horizontal and vertical target efficiency - a comparison between users and non-users of public long-term care in Sweden
Lagergren M; Sjolund B-M; Fagerstrom C; Berglund J; Fratiglioni L; Nordell E; Wimo A; Elmstahl S
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2014;28(1):97-103
Older patients referred by community nurses to emergency departments - a descriptive cross-sectional follow-up study in a Swedish context
Kihlgren A; Wimo A; Mamhidir A-G
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(3):304-316
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria
Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
Article: HERNIA. 2014;18(6):775-780
Cost analysis of the use of small stitches when closing midline abdominal incisions
Millbourn D; Wimo A; Israelsson LA
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2013;28(10):1039-1044
Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
Wimo A; Religa D; Spangberg K; Edlund A-K; Winblad B; Eriksdotter M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2013;37(2):357-365
Natural Progression Model of Cognition and Physical Functioning among People with Mild Cognitive Impairment and Alzheimer's Disease
Handels RLH; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FRJ; Severens JL; Fratiglioni L; Joore MA; Wimo A
Article: EUROPEAN HEART JOURNAL. 2013;34(33):2585-2591
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimers disease
Nordstrom P; Religa D; Wimo A; Winblad B; Eriksdotter M
Article: ALZHEIMERS & DEMENTIA. 2013;9(4):429-435.e17
Application of Resource Utilization in Dementia (RUD) instrument in a global setting
Wimo A; Gustavsson A; Jonsson L; Winblad B; Hsu M-A; Gannon B
Article: JOURNAL OF ALZHEIMERS DISEASE. 2013;36(2):385-399
The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Maria Haro J
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2013;28(5):454-462
Costs explained by function rather than diagnosis-results from the SNAC Nordanstig elderly cohort in Sweden
Lindholm C; Gustavsson A; Jonsson L; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2013;31(1):13-19
A Quick Test of Cognitive Speed (AQT): Usefulness in dementia evaluations in primary care
Kvitting AS; Wimo A; Johansson MM; Marcusson J
Article: CURRENT ALZHEIMER RESEARCH. 2013;10(2):207-216
Mortality and Treatment Costs have a Great Impact on the Cost-Effectiveness of Disease Modifying Treatment in Alzheimer's Disease - A Simulation Study
Skoldunger A; Johnell K; Winblad B; Wimo A
Article: ALZHEIMERS & DEMENTIA. 2013;9(1):1-11.e3
The worldwide economic impact of dementia 2010
Wimo A; Jonsson L; Bond J; Prince M; Winblad B
Article: CURRENT ALZHEIMER RESEARCH. 2012;9(10):1126-1134
Practical Lessons from Amyloid Immunotherapy Trials in Alzheimer Disease
Solomon A; Akenine U; Andreasen N; Mangialasche F; Wimo A; Jelic V; Kivipelto M; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2012;27(11):1112-1117
Net costs of dementia in Sweden - An Incidence Based 10 Year Simulation Study
Skoldunger A; Wimo A; Johnell K
Article: JOURNAL OF MEDICAL ECONOMICS. 2012;15(5):1019-1024
The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study.
Wimo A; Gaudig M; Schäuble B; Jedenius E
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2012;16(10):891-897
FEWER REFERRALS TO SWEDISH EMERGENCY DEPARTMENTS AMONG NURSING HOME PATIENTS WITH DEMENTIA, COMPREHENSIVE COGNITIVE DECLINE AND MULTICOMORBIDITY
Mamhidir A-G; Wimo A; Kihlgren A
Article: CURRENT ALZHEIMER RESEARCH. 2012;9(7):795-800
Dementia After Age 75: Survival in Different Severity Stages and Years of Life Lost
Rizzuto D; Bellocco R; Kivipelto M; Clerici F; Wimo A; Fratiglioni L
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2012;33(2-3):90-95
Dementia Diagnosis Differs in Men and Women and Depends on Age and Dementia Severity: Data from SveDem, the Swedish Dementia Quality Registry
Religa D; Spangberg K; Wimo A; Edlund A-K; Winblad B; Eriksdotter-Jonhagen M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2011;26(4):735-744
Cost-Effectiveness of a Health Intervention Program with Risk Reductions for Getting Demented: Results of a Markov Model in a Swedish/Finnish Setting
Zhang Y; Kivipelto M; Solomon A; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(8):825-832
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project
Wimo A; Jonsson L; Gustavsson A; McDaid D; Ersek K; Georges J; Gulacsi L; Karpati K; Kenigsberg P; Valtonen H
Article: ALZHEIMERS & DEMENTIA. 2011;7(3):318-327
Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients
Gustavsson A; Brinck P; Bergvall N; Kolasa K; Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL PSYCHOGERIATRICS. 2011;23(1):73-85
Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease
Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(1):56-64
Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons results from a 3-year follow-up population-based study
Wimo A; Sjolund BM; Skoldunger A; Johansson L; Nordberg G; von Strauss E
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2010;58(10):1855-1862
Morbidity and Physical Functioning in Old Age: Differences According to Living Area
Sjolund B-M; Nordberg G; Wimo A; von Strauss E
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):685-690
The resource utilization in dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia
Wimo A; Jonsson L; Zbrozek A
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):648-654
Differences in resource use and costs of dementia care between European countries: Baseline data from the ictus study
Gustavsson A; Jonsson L; Rapp T; Reynish E; Ousset PJ; Andrieu S; Cantet C; Winblad B; Vellas B; Wimo A
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):633-639
Costs of dementia in Hungary
Ersek K; Kovacs T; Wimo A; Karpati K; Brodszky V; Pentek M; Joensson L; Gustavsson A; Mcdaid D; Kenigsberg PA; Valtonen H; Gulacsi L
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_11):s323
P2‐036: Changes in care patterns over time in relation to cognitive and physical functioning of non demented and demented elderly people: Results from a 3‐year follow‐up population‐based study
Sjölund B-M; Wimo A; Sköldunger A; Johansson L; Nordberg G; Von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_11):s333
P2‐069: The use of drugs in demented and non‐demented people according to living situation; a comparison between rural and urban areas—results from SNAC, a population‐based multicenter study
Sköldunger AB; Sjölund B-M; Johnell K; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_12):s373
P2‐202: Dementia work‐up is more costly in men than in women
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Winblad B; Eriksdotter-Jonhagen M
Journal article: AGEING INTERNATIONAL. 2010;35(2):153-165
Caregiver Time and Cost of Home Care for Alzheimer’s Disease: A Clinic-based Observational Study in Beijing, China
Wang H; Gao T; Wimo A; Yu X
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(6):622-632
Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease
Gustavsson A; Jonsson L; McShane R; Boada M; Wimo A; Zbrozek AS
Article: CURRENT ALZHEIMER RESEARCH. 2010;7(4):358-367
Cross Sectional Observational Study on the Societal Costs of Alzheimer's Disease
Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jonsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(5):476-482
The cost of diagnosing dementia in a community setting
Jedenius E; Wimo A; Stromqvist J; Jonsson L; Andreasen N
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(5):358-360
IPECAD5-Fifth International Pharmaco-Economic Conference on Alzheimer's Disease
Gustavsson A; Jonsson L; Fillit H; Johansson G; Wimo A; Winblad B
Article: ALZHEIMERS & DEMENTIA. 2010;6(2):98-103
The worldwide societal costs of dementia: Estimates for 2009
Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL PSYCHOGERIATRICS. 2009;21(6):1116-1126
International price comparisons of Alzheimer's drugs: a way to close the affordability gap
Suh G-H; Wimo A; Gauthier S; O'Connor D; Ikeda M; Homma A; Dominguez J; Yang B-M
Journal article: JOURNAL OF NUTRITION HEALTH & AGING. 2009
IPECAD5 — Fifth International Pharmaco-Economic Conference on Alzheimer’s Disease
Gustavsson A; Jonsson L; Fillit H; Johansson G; Wimo A; Winblad B
Journal article: ALZHEIMERS & DEMENTIA. 2009;5(4S_Part_13):p410
P3‐228: Trends in informal care in Sweden: Is it decreasing? Cross‐sectional studies with the RUD instrument
Wimo A; Wimo A; Sjolund B; Jönsson L; Skoldunger A; Winblad B
Journal article: GERONTOLOGIE ET SOCIETE. 2009;vol. 32 / n° 128-129(1):297-318
Impact socio-économique de la maladie d'Alzheimer et des maladies apparentées en Europe
Kenigsberg P-A; Ersek K; Gulácsi L; Karpati K; Jacques A; Gustavsson A; Jönsson L; Mcdaid D; Valtonen H; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2009;5(4S_Part_13):p407
P3‐218: Health‐economic benefits of memantine treatment: Translating symptomatic effects into cost savings
Wirth Y; Wimo A
Article: LAKARTIDNINGEN. 2009;106(18-19):1277-1282
[Prevalence study of societal costs for dementia 2000-2005. More demented people--but somewhat reduced costs per person].
Wimo A; Johansson L; Jönsson L
Journal article: LANCET NEUROLOGY. 2009;8(1):39-47
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
Burns A; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Raivio M; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; Hammond GL; van Oene JC; Schwalen S
Journal article: AKTUELLE NEUROLOGIE. 2008;35(S 01)
Die SERAD Studie: Galantamin verbessert die Kognition bei Heimpatienten mit schwerer Alzheimerdemenz
Burns A; Ibach B; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Triau E; Vandewoude M; Wimo A; Came E; van Baelen B; van Oene J; Schwalen S
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_21):t700
P4‐106: Cognitive functioning in old age: Temporal trends in a rural area in Sweden
Sjölund B-M; Wimo A; Sköldunger A; von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_20):t650-t651
P3‐441: Net costs of dementia in Sweden: An incidence‐based 10‐year simulation study
Wimo A; Sköldunger A; Sjölund B-M
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_21):t682
P4‐049: The impact of dementia on life expectancy after age 75
Rizzuto D; Wimo A; Clerici F; Fratiglioni L
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2008;63(3):275-282
Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people
Melis RJF; Adang E; Teerenstra S; van Eiiken MIJ; Wimo A; van Achterberg T; de Lisdonk EHV; Rikkert MGMO
Article: HANDBOOK OF CLINICAL NEUROLOGY. 2008;89:137-146
Economical aspects of dementia.
Wimo A; Winblad B
Article: WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION. 2008;31(2):209-219
Health and disability pension - An intersection of disease, psychosocial stress and gender. Long term follow up of persons with impairment of the loco motor system
Kaiser P-O; Mattsson B; Marklund S; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2008;26(4):235-240
A Swedish programme for dementia diagnostics in primary healthcare
Jedenius E; Wimo A; Stromqvist J; Andreasen N
Journal article: ALZHEIMERS & DEMENTIA. 2007;3(3S_Part_3):s165
S1–01–01: Public health impact
Winblad B; Wimo A; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2007;3(3S_Part_2):s146
P‐148: The resource utilization in dementia (RUD) instrument is valid to assess informal care time in dementia
Wimo A; Jönsson L; Zbrozek AS
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(7):649-655
Health utilities in mild cognitive impairment and dementia:: a population study in Sweden
Ekman M; Berg J; Wimo A; Jonsson L; McBurney C
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(7):639-648
Time use and costs of institutionalised elderly persons with or without dementia:: results from the Nordanstig cohort in the Kungsholmen Project -: a population based study in Sweden
Nordberg G; Wimo A; Jonsson L; Kareholt I; Sjolund B-M; Lagergren M; von Strauss E
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(5):485-491
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
Winblad B; Kawata AK; Beusterien KM; Thomas SK; Wimo A; Lane R; Fillit H; Blesa R
Article: ALZHEIMERS & DEMENTIA. 2007;3(2):81-91
An estimate of the total worldwide societal costs of dementia in 2005
Wimo A; Winblad B; Jonsson L
Article: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2007;7(1):83-90
Cost-effectiveness of treatments for Alzheimer's dementia.
Wimo A; Norlund A
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2007;44(1):71-81
Validity and reliability of assessments of time - Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument
Wimo A; Nordberg G
Journal article: JOURNAL OF MENS HEALTH. 2006;3(4):373-378
Sense of coherence and vocational rehabilitation of persons with chronic musculoskeletal disorders–gender aspects
Kaiser P-O; Mattsson B; Marklund S; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2006;2(3S_Part_1):s19-s20
O1–05–08: The worldwide directs costs and costs of informal care of dementia
Winblad B; Wimo A; Jönsson L
Journal article: ALZHEIMERS & DEMENTIA. 2006;2(3S_Part_5):s138-s139
P1–146: Dementia and community costs in an area with a dementia program targeting early intervention. A study with an economic focus
Jedenius E; Wimo A; Strömqvist J; Andreasen N
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2006;10(4):255-262
Underweight, weight loss and related risk factors among older adults in sheltered housing - A Swedish follow-up study
Mamhidir AG; Ljunggren G; Kihlgren M; Kihlgren A; Wimo A
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2006;62(7):555-562
The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old
Klarin I; Fastbom J; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2006;21(5):449-459
Determinants of costs of care for patients with Alzheimer's disease
Jonsson L; Jonhagen ME; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Article: LAKARTIDNINGEN. 2006;103(13):1022-1028
[There is a need to reform dementia care. Resources are not used optimally--time for evidence-based care].
Marcusson J; Hoffman W; Klingén S; Minthon L; Sandman PO; Strömqvist J; Sundin Y; Wahlund L-O; Wimo A
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2006;34(6):584-588
More illness and less disease? A 20-year perspective on chronic disease and medication
Hagstrom B; Mattsson B; Wimo A; Gunnarsson RK
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006;21(5-6):353-363
3-year study of donepezil therapy in Alzheimer's disease: Effects of early and continuous therapy
Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm A-L; Haglund A; Zhang R; Schindler R
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006;20(1):49-55
Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL
Jönsson L; Andreasen N; Kilander L; Soininen H; Waldemar G; Nygaard H; Winblad B; Jönhagen ME; Hallikainen M; Wimo A
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006;21(3):175-181
An estimate of the worldwide prevalence and direct costs of dementia in 2003
Wimo A; Jonsson L; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2005;20(9):862-871
The amount of informal and formal care among non-demented and demented elderly persons -: Results from a Swedish population-based study
Nordberg G; von Strauss E; Kåreholt I; Johansson L; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2005;1(1S_Part_3):s101
[O2‐04‐01]: The worldwide costs of dementia
Winblad B; Jönsson L; Wimo A
Article: DRUGS & AGING. 2005;22(1):69-82
The association of inappropriate drug use with hospitalisation and mortality - A population-based study of the very old
Klarin I; Wimo A; Fastbom J
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2004;20(8):1221-1225
Impact of donepezil treatment for Alzheimer's disease on caregiver time
Wimo A; Winblad B; Shah SN; Chin W; Zhang R; McRae T
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2004;18(2):169-176
Older patients awaiting emergency department treatment
Kihlgren AL; Nilsson M; Skovdahl K; Palmblad B; Wimo A
Article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2004;16(2):158-168
A longitudinal study integrating population, care and social services data.: The Swedish National study on Aging and Care (SNAC)
Lagergren M; Fratiglioni L; Hallberg IR; Berglund J; Elmståhl S; Hagberg B; Holst G; Rennemark M; Sjölund BM; Thorslund M; Wiberg I; Winblad B; Wimo A
Article: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2003;3(6):675-680
Pharmacoeconomic aspects of memantine (Ebixa) in the treatment of Alzheimer's disease.
Wimo A
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2003;12(8):669-678
A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort
Klarin I; Fastbom J; Wimo A
Article: HERNIA. 2003;7(3):114-117
Cost analysis of incisional hernia repair by suture or mesh.
Israelsson LA; Jönsson L; Wimo A
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003;17(2):63-67
The magnitude of dementia occurrence in the world
Wimo A; Winblad B; Aguero-Torres H; von Strauss E
Article: PHARMACOECONOMICS. 2003;21(5):327-340
Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
Wimo A; Winblad B; Stoffler A; Wirth Y; Möbius HJ
Article: ACTA NEUROLOGICA SCANDINAVICA, SUPPLEMENT. 2003;107:94-99
Pharmacoeconomics of mild cognitive impairment
Wimo A; Winblad B
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003;15(1):44-54
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a 1-year, double-blind, randomized trial
Wimo A; Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Mastey V; Haglund A; Zhang R; Miceli R; Chin W; Subbiah P
Article: HEALTH POLICY. 2002;61(3):255-268
Time spent on informal and formal care giving for persons with dementia in Sweden
Wimo A; von Strauss E; Nordberg G; Sassi F; Johansson L
Article: PHARMACOECONOMICS. 2002;20(9):629-637
Assessment of health economics in Alzheimer's disease (AHEAD) - Treatment with galantamine in Sweden
Garfield FB; Getsios D; Caro JJ; Wimo A; Winblad B
Article: LAKARTIDNINGEN. 2001;98(38):4042-4048
Can the cost of future health care and social services needs of the elderly be calculated?
Wimo A; Jönsson L
Journal article: PSYCHOGERIATRICS. 2001;1(3):189-193
Health Economical Aspects of Alzheimer Disease and its Treatment
Wimo A; Winblad B
Article: NEUROLOGY. 2001;57(3):489-495
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wimo A; Wetterholm AL; Zhang R; Haglund A; Subbiah P
Article: DISABILITY AND REHABILITATION. 2001;23(10):430-435
The impact of psychosocial 'markers' on the outcome of rehabilitation
Kaiser PO; Mattsson B; Marklund S; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2000;15(10):969-971
Assessment of informal services to demented people with the RUD instrument
Wimo A; Nordberg G; Jansson W; Grafström M
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2000;10:368
Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimer's disease
Engedal K; Soininen H; Verhey F; Waldemar G; Winblad B; Wimo A; Wetterholm A-L; Zhang R; Haglund A; Subbiah P; Group TDNS
Article: BRITISH JOURNAL OF SURGERY. 2000;166(8):642-646
Cost minimisation analysis of change in closure technique of midline incisions
Israelsson LA; Wimo A
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000;14(3):137-140
Second International Pharmacoeconomic Conference on Alzheimer's Disease
Jönsson L; Jönsson B; Wimo K; Whitehouse P; Winblad B
Article: LAKARTIDNINGEN. 2000;97(20):2489-2493
[Troubled times in care of the elderly. Increasing number of the "oldest old" and demented, shortage of general practitioners and lack of clarity with regards to locating resources].
Wimo A
Journal article: NEUROBIOLOGY OF AGING. 2000;21:275
Validation of time estimates of the RUD instrument in dementia care
Nordberg G; Grafstroem M; Winblad B; Wimo A
Journal article: NEUROBIOLOGY OF AGING. 2000;21:274
Benefits of donepezil on cognition, function and/or neuropsychiatric symptoms in patients with Alzheimer's disease over one year
Waldemar G; Winblad B; Engedal K; Soininen H; Verhey F; Wimo A; Zhang R; Subbiah P
Journal article: NEUROBIOLOGY OF AGING. 2000;21:63
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial
Wimo A; Winblad B; Mastey V; Hertzman P; Haglund A; Miceli R; Jacobson L; Subbiah P
Journal article: NEUROBIOLOGY OF AGING. 2000;21:160-161
Response to donepezil is not predicted by apolipoprotein E genotype and/or gender
Soininen H; Winblad B; Engedal K; Waldemar G; Wimo A; Zhang R; Subbiah P
Journal article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999;13:s9-19
Assessing the Societal Impact of Acetylcholinesterase Inhibitor Therapies
Winblad B; Wimo A
Article: PHARMACOECONOMICS. 1999;16(4):409-416
Costs of mini mental state examination-related cognitive impairment
Jönsson L; Lindgren P; Wimo A; Jönsson B; Winblad B
Article: CLINICAL THERAPEUTICS. 1999;21(7):1230-1240
The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease:: A Markov model
Jönsson L; Lindgren P; Wimo A; Jönsson B; Winblad B
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 1999;28(3):227-237
'Misplacement' of elderly people in the caring organisation:: reasons and alternatives
Wimo A; Rönnbäck E; Larsson B; Eriksson T; Eriksson IB; Thorslund M
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 1999;28(3):205-216
Nursing load in different care alternatives in Sweden during 18 years
Wimo A; Rönnbäck E; Nyberg A; Granholm O; Thorslund M
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998;12(4):266-280
First International Pharmacoeconomic Conference on Alzheimer's Disease: Report and summary
Whitehouse PJ; Winblad B; Shostak D; Bhattacharjya A; Brod M; Brodaty H; Dor A; Feldman H; Forette F; Gauthier S; Hay J; Henke C; Hill S; Mastey V; Neumann P; O'Brien B; Pugner K; Sano M; Sawada T; Stone R; Wimo A
Article: CLINICAL THERAPEUTICS. 1998;20(3):552-566
Economic impact of introducing propentofylline for the treatment of dementia in Sweden
Wimo A; Witthaus E; Rother M; Winblad B
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997;11(4):191-200
Treatment of Alzheimer disease with tacrine: A cost-analysis model
Wimo A; Karlsson G; Nordberg A; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1997;12(8):857-861
Cost of illness due to dementia in Sweden
Wimo A; Karlsson G; Sandman PO; Corder L; Winblad B
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997;11:39-45
Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
Winblad B; Hill S; Beermann B; Post SG; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1995;13(3):205-210
CARE FOR DEMENTED PATIENTS IN DIFFERENT LIVING-CONDITIONS
WIMO A; ADOLFSSON R; SANDMAN PO
Article: INTERNATIONAL PSYCHOGERIATRICS. 1995;7(1):123-127
Patients with dementia in group living: experiences 4 years after admission.
Wimo A; Asplund K; Mattsson B; Adolfsson R; Lundgren K
Article: NORDISK MEDICIN. 1995;110(4):123-126
[Care of patients with dementia--a ticking cost bomb?].
Wimo A; Karlsson G; Sandman PO; Winblad B
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 1995;11(1):49-65
COST-UTILITY ANALYSIS OF GROUP LIVING IN DEMENTIA CARE
WIMO A; MATTSON B; KRAKAU I; ERIKSSON T; NELVIG A; KARLSSON G
Journal article: HEALTH ECONOMICS. 1994;3(6):395-404
Cost-effectiveness analysis of day care for patients with dementia disorders.
Wimo A; Mattsson B; Krakau I; Eriksson T; Nelvig A
Journal article: LAKARTIDNINGEN. 1994;91(22):2206-2207
[12 points for better care for the aged].
Brydolf G; Wimo A
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1994;9(6):479-489
The impact of cognitive decline and workload on the costs of dementia care
Wimo A; Krakau I; Mattsson B; Nelvig A
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1993;8(8):675-679
Assessments of productivity of psychogeriatric day care
Wimo A; Ineichen B; Mattson B; Kallioinen M
Journal article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1993;11(2):117-123
Dementia day care and its effects on symptoms and institutionalization--a controlled Swedish study.
Wimo A; Mattsson B; Adolfsson R; Eriksson T; Nelvig A
Journal article: INTERNATIONAL PSYCHOGERIATRICS. 1993;5(2):169-180
Can changes in ward routines affect the severity of dementia? A controlled prospective study.
Wimo A; Nelvig A; Nelvig J; Adolfsson R; Mattsson B; Sandman PO
Journal article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1992;10(3):185-191
Predictive validity of factors influencing the institutionalization of elderly people with psycho-geriatric disorders.
Wimo A; Gustafsson L; Mattson B
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1991;6(1):21-29
Group living, an alternative for dementia patients. A cost analysis
Wimo A; Wallin JO; Lundgren K; Rönnbäck E; Asplund K; Mattsson B; Krakau I
Journal article: FAMILY PRACTICE. 1990;7(4):279-287
Impact of day care on dementia patients--costs, well-being and relatives' views.
Wimo A; Wallin JO; Lundgren K; Rönnbäck E; Asplund K; Mattsson B; Krakau I
Journal article: LAKARTIDNINGEN. 1990;87(25):2175-2178
[Future geriatric care demands expanded capacity of small institutional units].
Wimo A; Lundkvist B; Strömberg G; Rönnbäck E; Ostman A; Backlund L; Brydolf G; Lundvall O
Journal article: LAKARTIDNINGEN. 1990;87(18):1555-1556
[Aggression and motor problems force persons with dementia to leave group dwellings].
Asplund K; Wimo A; Lundgren K
Journal article: LAKARTIDNINGEN. 1988;85(48):4202-4207
[A cross-sectional study in Sundsvall. 90-year-old persons are healthier than expected. The majority live in their own flats].
Wimo A; Strömberg E; Elfving G; Brydolf G
Show more

All other publications

Preprint: MEDRXIV. 2024
New IPECAD open-source model framework for the health technology assessment of early Alzheimer’s disease treatment: development and use cases
Handels R; Herring WL; Grimm S; Sköldunger A; Winblad B; Wimo A; Jönsson L
Review: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):281-291
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Wahlberg K; Winblad B; Cole A; Herring WL; Ramsberg J; Torontali I; Visser P-J; Wimo A; Wollaert L; Jonsson L
Review: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(5):1212-1218
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators.
Jessen F; Kramberger MG; Angioni D; Aarsland D; Balasa M; Bennys K; Boada M; Boban M; Chincarini A; Exalto L; Felbecker A; Fliessbach K; Frisoni GB; Garza-Martínez AJ; Grimmer T; Hanseeuw B; Hort J; Ivanoiu A; Klöppel S; Krajcovicova L; McGuinness B; Mecocci P; de Mendonca A; Nous A; Ousset P-J; Paquet C; Perneczky R; Peters O; Tabuas-Pereira M; Piazza F; Plantone D; Riverol M; Ruiz A; Sacco G; Santana I; Scarmeas N; Solje E; Stefanova E; Sutovsky S; van der Flier W; Welsh T; Wimo A; Winblad B; Frölich L; Engelborghs S
Editorial comment: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(4):895-896
On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use
Zhou RZ; Wimo A; Winblad B
Conference publication: VALUE IN HEALTH. 2023;26(12):s1
P3 Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease
Handels R; Wimo A; Skoldunger A; Tate A; Winblad B; Silvertand D; Nguyen L; Jönsson L; Grimm S; Aye S; Herring W
Letter: ALZHEIMERS & DEMENTIA. 2023;19(10):4760-4763
Response to "Comment on 'Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program'"
Wimo A; Handels R; Antikainen R; Eriksdotter M; Jonsson L; Knapp M; Kulmala J; Laatikainen T; Lehtisalo J; Peltonen M; Skoldunger A; Soininen H; Solomon A; Strandberg T T; Tuomilehto J; Ngandu T; Kivipelto M
Conference publication: VALUE IN HEALTH. 2023;26(12):S1
OPEN-SOURCE MODEL FRAMEWORK FOR HEALTH-ECONOMIC EVALUATION OF EARLY TREATMENT IN ALZHEIMER'S DISEASE
Handels R; Wimo A; Skoldunger A; Tate A; Winblad B; Silvertand D; Nguyen L; Jonsson L; Grimm S; Aye S; Herring W
Editorial comment: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2023;10(3):349-352
Amyloid-targeting New Therapies for Alzheimer's Disease: A Health Economics Perspective
Jonsson L; Wimo A
Review: PHARMACOECONOMICS. 2023;41(1):59-75
The Costs of Dementia in Europe: An Updated Review and Meta-analysis
Jonsson L; Tate A; Frisell O; Wimo A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2022;29:74
The COVID-19 pandemic has caused large disruptions to dementia mortality, care, and diagnosis in Sweden during 2020
Winblad B; Schedin-Weiss S; Tjernberg L; Wimo A; Bucht G; Eriksdotter M; Axenhus M
Editorial comment: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2021;21(1):1-4
What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?
Wimo A
Editorial comment: INTERNATIONAL PSYCHOGERIATRICS. 2020;32(5):1-6
Time to invest in prevention and better care of behaviors and psychological symptoms associated with dementia
Burley CV; Livingston G; Knapp MRJ; Wimo A; Norman R; Brodaty H
Review: AGING & MENTAL HEALTH. 2020;24(2):200-211
Interventions to enhance access to and utilization of formal community care services for home dwelling persons with dementia and their informal carers. A scoping review
Rosvik J; Michelet M; Engedal K; Bieber A; Broda A; Goncalves-Pereira M; Hopper L; Irving K; Jelley H; Kerpershoek L; Meyer G; Marques MJ; Portolani E; Sjolund B-M; Skoldunger A; Stephan A; Verhey F; de Vugt M; Woods B; Wolfs C; Zanetti O; Selbaek G; Handels R; Bartoszek G; Orrell M; Wimo A; Eriksen S; Joyce R; Balsinha MC; Machado A
Review: ALZHEIMERS & DEMENTIA. 2019;15(6):828-839
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community
Rodriguez-Gomez O; Rodrigo A; Iradier F; Santos-Santos MA; Hundemer H; Ciudin A; Sannemann L; Zwan M; Glaysher B; Wimo A; Bonn J; Johansson G; Rodriguez I; Alegret M; Gove D; Pino S; Trigueros P; Kivipelto M; Mathews B; Ciudad A; Ferreira D; Bintener C; Gurruchaga M; Westman E; Belger M; Valero S; Maguire P; Krivec D; Kramberger M; Simo R; Garro IP; Visser PJ; Dumas A; Georges J; Jessen F; Winblad B; Shering C; Stewart N; Campo L; Boada M
Conference publication: EUROPEAN PSYCHIATRY. 2017;41:S652
The Portuguese participation in the Actifcare (access to timely formal care in dementia) European study: Preliminary results of systematic reviews, qualitative and quantitative data
Goncalves-Pereira M; Marques MJ; Balsinha C; Reis T; Machado A; Barrios H; Alves L; Verdelho A; Meyer G; Woods B; Wimo A; Selbaeck G; Irving K; Zanetti O; Orrell M; De Vugt M; Verhey F
Corrigendum: ALZHEIMERS RESEARCH & THERAPY. 2017;9(1):12
The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care (vol 8, 59, 2016)
Wimo A; Jonsson L; Fratiglioni L; Sandman PO; Gustavsson A; Skoldunger A; Johansson JL
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2017;24:528
Estimates of health-care and societal costs as a function of pre-institutionalisation time in patients with Alzheimer's disease dementia
Reed C; Belger M; Haro JM; Dell'Agnello G; Wimo A
Meeting abstract: VALUE IN HEALTH. 2016;19(7):A377
CURRENT ISSUES AND FUTURE RESEARCH PRIORITIES FOR HEALTH ECONOMIC MODELLING OF AT RISK POPULATION FOR ALZHEIMER'S DISEASE/DEMENTIA
Gustavsson A; Green C; Jones RW; Simsek D; de Vulpillieres DRF; Adlard N; Bhattacharyya S; Wimo A; ForstlFoerstl H; Luthman S
Corrigendum: BMC HEALTH SERVICES RESEARCH. 2016;16(1):620
Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study(vol 16, 423, 2016)
Kerpershoek L; de Vugt M; Wolfs C; Jelley H; Orrell M; Woods B; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Conference publication: GERONTOLOGIST. 2016;56:389
COGNITIVE IMPAIRMENT AND RESOURCE USE IN SWEDISH NURSING HOMES: RESULTS FROM THE SVENIS STUDY
Skldunger AB; Wimo A; Sandman P; Backman A; Edvardsson D
Editorial comment: LANCET NEUROLOGY. 2015;14(12):1145-1146
Long-term effects of Alzheimer's disease treatment
Wimo A
Conference publication: VALUE IN HEALTH. 2015;18(7):A759-A760
COMPARING RESOURCE USE IN ALZHEIMER'S DISEASE ACROSS THREE EUROPEAN COUNTRIES-18-MONTH RESULTS OF THE GERAS STUDY
Belger M; Arigmon JM; Dodel R; Haro JM; Wimo A; Reed C
Conference publication: VALUE IN HEALTH. 2015;18(7):A760
HOW USEFUL ARE EQ-5D AND ZBI IN ASSESSING THE IMPACT OF CARING FOR ALZHEIMER'S DISEASE PATIENTS?
Reed C; Barrett A; Lebrec J; Dodel R; Jones RW; Vellas B; Wimo A; Argimon JM; Bruno G; Haro JM
Editorial comment: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2015;16(9):720-721
Brain Health: A Primary Health Care Viewpoint
Wimo A; Winblad B
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S34-S35
Access to formal dementia care: Results from a systematic review and a European focus group study
Stephan A; Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Bieber A; Meyer G; Pereira MG; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S35-S36
Access to timely care in Portugal as compared to other European countries
Pereira MG; Stephan A; Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Bieber A; Meyer G; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S34
Background and rationale of the Actifcare project
Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Stephan A; Bieber A; Meyer G; Pereira MG; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: VALUE IN HEALTH. 2014;17(3):A185
HOW TO DEAL WITH MISSING LONGITUDINAL DATA IN COST OF ILLNESS MODELS IN ALZHEIMER'S DISEASE - SUGGESTIONS FROM THE GERAS STUDY RESULTS
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Wimo A
Review: ALZHEIMERS & DEMENTIA. 2013;9(1):63-75.e2
The global prevalence of dementia: A systematic review and metaanalysis
Prince M; Bryce R; Albanese E; Wimo A; Ribeiro W; Ferri CP
Conference publication: VALUE IN HEALTH. 2012;15(7):A554
HEALTH STATE VALUES IN ALZHEIMER'S DISEASE - BASELINE RESULTS FROM A LARGE PROSPECTIVE OBSERVATIONAL STUDY IN THREE EUROPEAN COUNTRIES (GERAS)
Reed C; Argimon J; Belger MA; Bruno G; Dodel R; Happich M; Haro JM; Jones RW; Vellas B; Wimo A
Conference publication: VALUE IN HEALTH. 2012;15(7):A527
HEALTH CARE RESOURCE USE AND COST IN ALZHEIMER'S DISEASE IN THREE EUROPEAN COUNTRIES - BASELINE FINDINGS OF THE GERAS STUDY
Reed C; Argimon J; Belger MA; Bruno G; Dodel R; Happich M; Haro JM; Jones RW; Vellas B; Wimo A
Conference publication: NEUROBIOLOGY OF AGING. 2012;33:S36
GLOBAL PHARMACOECONOMICS OF ALZHEIMER'S DISEASE IN LIGHT OF POTENTIAL COST EFFECTIVENESS OF DISEASE MODIFYING TREATMENT
Wimo A
Conference publication: VALUE IN HEALTH. 2011;14(7):a289
MORTALITY IN RELATION TO DISEASE SEVERITY IN SUBJECTS WITH DEMENTIA
Jonsson L; Fratiglioni L; Wimo A
Book chapter: PRINCIPLES AND PRACTICE OF GERIATRIC PSYCHIATRY. 2010;p. 90-96
Economics of Ageing and Mental Health
Wimo A
Editorial comment: JOURNAL OF ALZHEIMERS DISEASE. 2010;19(2):617-619
The Art of Cost of Illness
Wimo A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2010;17:75
Age affects quality and cost of dementia diagnosis
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Winblad B; Jonhagen ME
Other: LAKARTIDNINGEN. 2009;106(49):3357
[Diagnosis of dementia in the elderly is not unnecessary].
Jönhagen ME; Edlund A-K; Eriksson S; Granqvist N; Kilander L; Mattson U-B; Nelvig A; Nägga K; Wimo A; Winblad B
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2009;16:358
The lower cost of dementia diagnosis in women
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Johansson N; Winblad B; Eriksdotter MJ
Review: PHARMACOECONOMICS. 2009;27(5):391-403
The Cost of Dementia in Europe A Review of the Evidence, and Methodological Considerations
Jonsson L; Wimo A
Review: LANCET NEUROLOGY. 2008;7(9):812-826
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
Kalaria RN; Maestre GE; Arizaga R; Friedland RP; Galasko D; Hall K; Luchsinger JA; Ogunniyi A; Perry EK; Potocnik F; Prince M; Stewart R; Wimo A; Zhang Z-X; Antuono P
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2008;15:222
The SERAD study: galantamine improves cognitive function in nursing home patients with severe Alzheimer's disease
Burns A; Bernabei R; Bullock R; Jentoft AJC; Frolich L; Hock C; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; van Oene JC; Schwalen S
Editorial comment: ALZHEIMERS & DEMENTIA. 2007;3(3):157-161
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cost-effectiveness studies
Wimo A; Norlund A
Published conference paper: INTERNATIONAL PSYCHOGERIATRICS. 2007;19(3):497-507
Clinical and economic outcomes - friend or foe?
Wimo A
Book chapter: SEVERE DEMENTIA. 2006;p. 227-236
Health Economics of Severe Dementia
Wimo A; Winblad B
Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S23
Cholinesterase inhibitors for AD therapy: Are they worth the price?
Wimo A
Corrigendum: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006;20(2):125
Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. (vol 20, pg 49, 2006)
Jonsson L; Andreasen N; Kilander L; Soininen H; Waldemar G; Nygaard H; Winblad B; Eriksdotter JM; Hallikainen M; Wimo A
Book chapter: STANDARDS IN DEMENTIA CARE. 2005;p. 326-333
Government perspectives England
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:334-335
The amount of informal and formal care among non-demented and demented elderly persons - Result from a Swedish population based study
Nordberg G; von Strauss E; Kareholt I; Johansson L; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:34-35
Treatment with glutamatergic antagonists: current pharmacoeconomic data
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:8
Are treatments for dementia worth it? A health economic perspective
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:337-338
SveDem, how do you do, Sweden?
Spangberg K; Jonhagen ME; Fratiglioni L; Graff C; Minthon L; Sandman PO; Wimo A; Marcusson J; Eriksson S; Johansson G; Winblad B
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:s346
Societal costs of dementia in Sweden:: An application of the rud-instrument in a population-based study
Wimo AB; Winblad B; Nordberg G; von Stauss E; Sjölund BM
Conference publication: NEUROBIOLOGY OF AGING. 2004;25:S28
From resource utilization to costs: How and how much and why?
Wimo A
Review: DRUGS & AGING. 2004;21(5):279-295
Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease - A review with methodological considerations
Wimo A
Review: CURRENT PHARMACEUTICAL DESIGN. 2004;10(3):295-301
Economic aspects on drug therapy of dementia
Wimo A; Winblad B
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:S404
Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study
Winblad B; Wimo A; Wetterholm AL; Haglund A; Engedal K; Soininen H; Verhey FRJ; Waldemar G; Zhang R; Burger L; Schindler R
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:S402-S403
Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a-one-year placebo-controlled study and participated in a two-year follow-up study
Winblad B; Engedal K; Soininen H; Verhey FRJ; Waldemar G; Wimo A; Wetterholm AL; Haglund A; Zhang R; Burger L; Schindler R
Meeting abstract: VALUE IN HEALTH. 2003;6(3):276
Caregiver health benefits and associated reductions in healthcare costs as a consequence of treating patients with donepezil
Winblad B; Wimo A; Mastey V; Shah S; Haglund A; Zhang R; Miceli R; Chin W
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:322
Donepezil treatment in Alzheimer's disease patients: Caregiver health benefits and associated reductions in healthcare costs
Wimo A; Winblad B; Shah S; Haglund A; Zhang R; Chin W
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:293-294
Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study
Winblad B; Engedal K; Soininen H; Waldemar G; Verhey F; Wimo A; Wetterholm AL; Haglund A; Zhang R; Burger L; Schindler R
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:292-293
Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study
Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wimo A; Wetterholm AL; Zhang R; Burger L; Schindler R
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:149
Cost effectiveness of treatments of dementia
Winblad B; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:320-321
Comparison of dementia prevalence in an urban and a rural population in Sweden:: Data from the Kungsholmen-Nordanstig project
Von Strauss EI; Nordberg GK; Sjölund BM; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:155
Comorbidity and costs of dementia
Wimo A; Klarin I; Sjolund BM; Von Strauss EI
Published conference paper: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:251-256
Societal burden and economics of vascular dementia: Preliminary results from a Swedish-population-based study
Wimo A; Winblad B
Book chapter: DEMENTIA. 2002;p. 341-387
Costs of Dementia: A Review
Jönsson B; Jönsson L; Wimo A
Conference publication: NEUROBIOLOGY OF AGING. 2002;23(1):S144-S145
Pharmacoeconomics and dementia
Wimo A
Book chapter: ALZHEIMER'S DISEASE. 2001;p. 725-738
Benefits of Donepezil on Cognition, Function and Neuropsychiatric Symptoms in Patients with Mild and Moderate Alzheimer's Disease over One Year
Waldemar G; Winblad B; Engedal K; Soininen H; Verhey F; Wimo A; Wetterholm A; Zhang R; Haglund A; Subbiah P
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2001;49(4):S131
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial.
Mastey V; Wimo A; Winblad B; Haglund A; Jacobson L; Miceli R; Zhang R; Subbiah P
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2001;49(4):S20
Donepezil reduces the time caregivers spend providing care: Results of a one-year, double-blind randomized trial in patients with mild to moderate Alzheimer's disease.
Mastey V; Wimo A; Winblad B; Haglund A; Jacobson L; Miceli R; Zhang R; Subbiah P
Published conference paper: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2000;11:3-10
Outcome measures in Alzheimer's disease: Do they go far enough?
Winblad B; Wimo A; Almkvist O
Book chapter: DEMENTIA. 2000;p. 335-381
Costs of Dementia: A Review
Jönsson B; Jönsson L; Wimo A
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2000;48(8):S107
Long-term benefits of donepezil on ADLs in AD patients.
Soininen H; Winblad B; Engedal K; Verhey F; Wimo A; Wetterholm AL; Zhang R; Haglund A; Subbiah P
Editorial comment: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1999;14(11):911-914
Severe dementia:: A common condition entailing high costs at individual and societal levels
Winblad B; Wimo A; Möbius HJ; Fox JM; Fratiglioni L
Published conference paper: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999;13:S9-19
Assessing the societal impact of acetylcholinesterase inhibitor therapies
Winblad B; Wimo A
Review: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1999;14(5):338-347
The social consequences for families with Alzheimer's disease patients: Potential impact of new drug treatment
Wimo A; Winblad B; Grafstrom M
Review: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1997;12(8):841-856
Costs of dementia and dementia care: A review
Wimo A; Ljunggren G; Winblad B
Letter: LAKARTIDNINGEN. 1996;93(13):1200
[More accurate diagnosis could identify patients suitable for tacrine therapy].
Andreasen N; Eriksson S; Karlsson I; Lindahl B; Lund M; Nordberg A; Wimo A; Winblad B; Astrand R
Published conference paper: ACTA NEUROLOGICA SCANDINAVICA, SUPPLEMENT. 1996;94:101-104
What are the costs to society and to individuals regarding diagnostic procedures and care of patients with dementia?
Winblad B; Ljunggren G; Karlsson G; Wimo A
Show more

About me

Research

Articles

All other publications

News from KI

Events from KI